These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 35608678)

  • 1. SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness.
    Monin MB; Marx B; Meffert L; Boesecke C; Rockstroh JK; Strassburg CP; Brossart P; Heine A
    Ann Hematol; 2022 Sep; 101(9):2089-2090. PubMed ID: 35608678
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.
    Wheeler SE; Shurin GV; Yost M; Anderson A; Pinto L; Wells A; Shurin MR
    Microbiol Spectr; 2021 Sep; 9(1):e0034121. PubMed ID: 34346750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    Kadyrova I; Yegorov S; Negmetzhanov B; Kolesnikova Y; Kolesnichenko S; Korshukov I; Akhmaltdinova L; Vazenmiller D; Stupina Y; Kabildina N; Ashimova A; Raimbekova A; Turmukhambetova A; Miller MS; Hortelano G; Babenko D
    PLoS One; 2022; 17(7):e0272008. PubMed ID: 35895743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
    Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Testing Landscape Post-Infection, -Vaccination, and Future Perspectives.
    Sabalza M; Heckler I; Elhage A; Venkataraman I; Henry B
    Viral Immunol; 2022; 35(1):5-14. PubMed ID: 35020523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report.
    Spinner JA; Julien CL; Olayinka L; Dreyer WJ; Bocchini CE; Munoz FM; Devaraj S
    J Heart Lung Transplant; 2022 Feb; 41(2):133-136. PubMed ID: 34911654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Among 1.6 Million Blood Donors: Impact of Vaccination, United States, December 2020-June 2021.
    Dodd RY; Notari EP; Brodsky JP; Foster GA; Xu M; Saá P; Stramer SL
    J Infect Dis; 2022 Jan; 225(1):5-9. PubMed ID: 34626465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination.
    Mades A; Chellamathu P; Kojima N; Lopez L; MacMullan MA; Denny N; Angel AN; Santacruz M; Casian JG; Brobeck M; Nirema N; Klausner JD; Turner F; Slepnev VI; Ibrayeva A
    Sci Rep; 2021 Dec; 11(1):24448. PubMed ID: 34961780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of Anti-SARS CoV-2 Antibodies following Vaccination: Valuable Monitoring or Irrelevant Tool?].
    Lotz C; Herrmann J; Hübsch ME; Notz Q; Meybohm P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2022 Apr; 57(4):302-306. PubMed ID: 35451036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
    van Gils MJ; van Willigen HDG; Wynberg E; Han AX; van der Straten K; Burger JA; Poniman M; Oomen M; Tejjani K; Bouhuijs JH; Verveen A; Lebbink R; Dijkstra M; Appelman B; Lavell AHA; Caniels TG; Bontjer I; van Vught LA; Vlaar APJ; Sikkens JJ; Bomers MK; Russell CA; Kootstra NA; Sanders RW; Prins M; de Bree GJ; de Jong MD;
    Cell Rep Med; 2022 Jan; 3(1):100486. PubMed ID: 35103254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2.
    Bi X; Takayama T; Tokoro M; Mizuno T; Hara A; Nakamura H; Oe H; Nagamatsu S; Kitano Y; Ichimura H
    Microbiol Spectr; 2022 Apr; 10(2):e0023822. PubMed ID: 35384720
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.
    Mattiuzzi C; Lippi G
    J Infect Public Health; 2022 Apr; 15(4):395-396. PubMed ID: 35299063
    [No Abstract]   [Full Text] [Related]  

  • 16. Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination.
    Shapira G; Abu Hamad R; Weiner C; Rainy N; Sorek-Abramovich R; Benveniste-Levkovitz P; Rock R; Avnat E; Levtzion-Korach O; Bar Chaim A; Shomron N
    FASEB J; 2022 Apr; 36(4):e22223. PubMed ID: 35239233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 diagnosis, but not vaccination, was linked to increased risk for immune-mediated neurologic events.
    Forster D
    Ann Intern Med; 2022 Jul; 175(7):JC82. PubMed ID: 35785537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.
    Glück V; Grobecker S; Köstler J; Tydykov L; Bertok M; Weidlich T; Gottwald C; Salzberger B; Wagner R; Zeman F; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
    Infection; 2022 Apr; 50(2):439-446. PubMed ID: 34562263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.